Full Text View
Tabular View
Study Results
Related Studies
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
This study has been completed.
Study NCT01185782   Information provided by Merck KGaA

First Received on August 11, 2010.   Last Updated on January 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infertility
Ovulation Induction
More general conditions related to this trial
Genital Diseases, Female
Genital Diseases, Male
Interventions listed in this trial
Gonalef® (Follitropin alfa)
Additional drug interventions recognized in this trial
Follicle Stimulating Hormone
Gonadotropins, Pituitary
Hormones
More general drug interventions related to this trial
Fertility Agents
Fertility Agents, Female
Fertility Agents, Male
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Merck KGaA
Merck Serono Co., Ltd., Japan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services